MedTrace Logo

Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up

NCT00198341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1775

Last updated 2022-08-10

No results posted yet for this study

Summary

The follow-up of patients operated on for lung cancer is heterogeneous. An intensive follow-up including routine clinic visits, chest X-rays, chest computed tomography (CT) scans and fiberoptic bronchoscopies might detect more small, potentially curable, recurrences and second cancers. However, as it appears in the American Society of Clinical Oncology (ASCO) recommendations, a large randomized study is necessary to evaluate the survival impact of such a follow-up strategy. This is the main objective of this IFCT-0302 study, which is a large randomized controlled study conducted in France comparing this intensive follow-up to a follow-up with only routine clinic visits and chest X-rays.

Conditions

  • Non-Small-Cell Lung Carcinoma

Interventions

PROCEDURE

Radiological Arm

Clinical Visit + X-Ray Chest

PROCEDURE

Scannographic arm

Clinical visit + X-Ray Chest + CT-Scan + Fibroscopy (for squamous cell)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER

  • Intergroupe Francophone de Cancerologie Thoracique

    lead OTHER

Principal Investigators

  • Virginie Westeel, Pr · Centre Hospitalier Universitaire de Besancon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2018-05-31
Completion
2022-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00198341 on ClinicalTrials.gov